ASN
AMPH icon

Advisory Services Network’s Amphastar Pharmaceuticals AMPH Stock Holding History

Advisory Services Network’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-47
Closed -$2.91K – 1529
2023
Q4 		$2.91K Buy
+47
New +$2.47K ﹤0.01% 3285
2023
Q2 		– Sell
-100
Closed -$3.75K – 1514
2023
Q1 		$3.75K Buy
+100
New +$3.28K ﹤0.01% 3246
2020
Q4 		– Sell
-42
Closed -$817 – 3275
2020
Q3 		$1K Buy
+42
New +$846 ﹤0.01% 3259

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Advisory Services Network's AMPH Position: Q1 2024 in Review

Advisory Services Network sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 47 shares — an estimated $2.91K sold.

Advisory Services Network first reported a position in AMPH in Q3 2020 and held it in 3 quarters. The position peaked at $3.75K in Q1 2023. 270 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

  • Advisory Services Network reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 47 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $2.91K.
  • Advisory Services Network first reported a position in Amphastar Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Advisory Services Network's Amphastar Pharmaceuticals position peaked at $3.75K in Q1 2023.
  • 270 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.